Changes in the liver concentrations of the nicotinamide adenine dinucleotide coenzymes and in the activities of oxidoreductase enzymes following treatment of the rat with ethyl chlorophenoxyisobutyrate (Atromid-S).
D000738:Androsterone / Q000494:pharmacology*; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001835:Body Weight; D002087:Butyrates / Q000494:pharmacology*; D003067:Coenzymes / Q000032:analysis; D003576:Electron Transport Complex IV / Q000032:analysis; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D005969:Glutamate Dehydrogenase / Q000032:analysis; D007521:Isocitrate Dehydrogenase / Q000032:analysis; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008099:Liver / Q000032:analysis*; D008291:Malate Dehydrogenase / Q000032:analysis; D008297:Male; D009243:NAD / Q000032:analysis*; D009249:NADP / Q000032:analysis*; D009929:Organ Size; D010734:Phosphogluconate Dehydrogenase / Q000032:analysis; D051381:Rats; D013053:Spectrophotometry; D014366:Tryptophan Oxygenase
D000924:Anticholesteremic Agents; D002087:Butyrates; D003067:Coenzymes; D009243:NAD; D009249:NADP; D000738:Androsterone; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D014366:Tryptophan Oxygenase; D005969:Glutamate Dehydrogenase; D003576:Electron Transport Complex IV